TAJ PHARMA – Oncology & Supportive Care Products List

Advancing Global Cancer Care Through Quality and Innovation

Cancer remains one of the leading causes of mortality worldwide, creating an urgent need for accessible, affordable, and high-quality oncology medicines. As healthcare systems continue to expand cancer treatment programs, pharmaceutical manufacturers play a critical role in ensuring uninterrupted access to life-saving therapies.

Taj Pharma has established itself as a trusted pharmaceutical manufacturer with a growing portfolio of oncology and supportive care products designed to meet the needs of hospitals, oncology centers, government procurement agencies, and international distributors. Through its commitment to quality, regulatory compliance, and patient-centered healthcare solutions, Taj Pharma continues to support global efforts in cancer management.

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
AnastrozoleANASTROTAJHormonal Anticancer (Aromatase Inhibitor)Tablet1 mgII
Vincristine SulphateVINCRITAJVinca Alkaloid AnticancerLyophilised Powder for Injection / Injection2 mg/mLIV
BendamustineBENDATAJAlkylating AnticancerLyophilised Powder for Injection100 mg/vialIII
BortezomibBORTEZTAJProteasome Inhibitor AnticancerInjection Vial2 mg/mLIV
Bortezomib (Lyophilised)BORTEZTAJ-LYOProteasome Inhibitor AnticancerLyophilised Injection Vial3.5 mg/vialIV
CabozantinibCABOTAJTyrosine Kinase InhibitorTablet40 mgII
CapecitabineCAPETAJAntimetabolite AnticancerTablet500 mg, 1 gIII
CyclophosphamideCYCLOTAJAlkylating AnticancerInjection Vial500 mg/vialIII
CyclophosphamideCYCLOTAJAlkylating AnticancerTablet50 mgIII
DacarbazineDACARTAJAlkylating AnticancerPowder for Injection200 mg/vialIII
DasatinibDASATAJTyrosine Kinase InhibitorTablet20 mgIV
DenosumabDENOTAJRANKL Inhibitor / Bone Metastasis Supportive CareInjection Vial120 mg/vialBiologic
EnzalutamideENZATAJAndrogen Receptor InhibitorTablet40 mgII
EtoposideETOPTAJTopoisomerase II InhibitorInjection Vial100 mg/5 mLIV
EtoposideETOPTAJTopoisomerase II InhibitorCapsule50 mgIV
EverolimusEVEROTAJmTOR InhibitorTablet10 mgII
Fluorouracil (5-FU)FLUOROTAJAntimetabolite AnticancerInjection500 mg/10 mLIII
FulvestrantFULVETAJSelective Estrogen Receptor Degrader (SERD)Injection Vial250 mg/5 mLII
ImatinibIMATITAJTyrosine Kinase InhibitorTablet / Capsule100 mg, 400 mgIII
InterferonINTERTAJImmunomodulator / Biologic AnticancerInjection Vial300 mg/vial*Biologic
IrinotecanIRINOTAJTopoisomerase I InhibitorInjection Vial100 mg/5 mLIV
LapatinibLAPATAJTyrosine Kinase InhibitorTablet250 mgII
LomustineLOMUSTAJNitrosourea AnticancerCapsule40 mgII
MesnaMESNATAJUroprotective Supportive CareInjection Ampoule / Vial200 mgIII
MesnaMESNATAJUroprotective Supportive CareOral Capsule600 mgIII
MethotrexateMETHOTAJAntimetabolite AnticancerInjection Vial1000 mg/10 mLIII
OctreotideOCTREOTAJSomatostatin AnalogueInjection Vial50 mg*Peptide/Biologic-like
PomalidomidePOMALITAJImmunomodulatory AnticancerCapsule4 mgIV
SorafenibSORATAJTyrosine Kinase InhibitorCapsule / Tablet200 mgII
Zoledronic AcidZOLETAJBisphosphonate / Bone Metastasis Supportive CareInjection Vial5 mg/vialIII
OndansetronONDATAJAntiemetic (5-HT3 Antagonist)Injection2 mg/mL in 2 mLIII

Comprehensive Oncology Product Portfolio

Taj Pharma offers a diverse range of oncology medicines covering multiple therapeutic categories, including:

Hormonal Therapies

Hormonal therapies are essential in the treatment of hormone-sensitive cancers such as breast and prostate cancer.

Products include:

  • Anastrozole Tablets
  • Fulvestrant Injection
  • Enzalutamide Tablets

These medicines help inhibit hormone activity that can stimulate cancer growth and are widely used in modern oncology treatment protocols.

Targeted Cancer Therapies

Targeted therapies represent one of the most significant advances in oncology, focusing on specific molecular pathways involved in cancer progression.

Taj Pharma’s targeted therapy portfolio includes:

  • Imatinib Tablets/Capsules
  • Dasatinib Tablets
  • Cabozantinib Tablets
  • Sorafenib Tablets/Capsules
  • Lapatinib Tablets
  • Everolimus Tablets
  • Bortezomib Injection

These therapies are widely used in the treatment of leukemia, renal cancer, hepatocellular carcinoma, breast cancer, gastrointestinal stromal tumors, and multiple myeloma.

Cytotoxic and Chemotherapeutic Agents

Conventional chemotherapy continues to be a cornerstone of cancer treatment worldwide.

Taj Pharma manufactures important chemotherapy agents such as:

  • Cyclophosphamide Tablets and Injection
  • Bendamustine Lyophilized Injection
  • Dacarbazine Injection
  • Vincristine Sulphate Injection
  • Etoposide Capsules and Injection
  • Fluorouracil Injection
  • Methotrexate Injection
  • Irinotecan Injection
  • Lomustine Capsules
  • Capecitabine Tablets

These products are used across a broad spectrum of malignancies including breast cancer, colorectal cancer, lymphomas, leukemias, lung cancer, and gastrointestinal cancers.

Hematology and Multiple Myeloma Solutions

The increasing prevalence of hematological malignancies has created demand for specialized therapies.

Taj Pharma’s portfolio includes:

  • Bortezomib Injection
  • Pomalidomide Capsules
  • Imatinib Tablets
  • Dasatinib Tablets

These products support treatment regimens for multiple myeloma, chronic myeloid leukemia, and other hematologic disorders.

Supportive Care Portfolio

Effective cancer treatment requires comprehensive supportive care to manage treatment-related complications and improve patient outcomes.

Bone Health Management

Cancer patients with bone metastases often require specialized therapies to reduce skeletal complications.

Available products include:

  • Zoledronic Acid Injection
  • Denosumab Injection

These medicines help reduce bone-related events and improve quality of life in oncology patients.

Antiemetic Therapy

Chemotherapy-induced nausea and vomiting remain common treatment challenges.

Taj Pharma offers:

  • Ondansetron Injection

This product helps improve patient comfort and treatment adherence during chemotherapy.

Uroprotective Agents

Certain chemotherapy regimens require bladder protection.

Available product:

  • Mesna Injection
  • Mesna Oral Capsules

Mesna is widely used to prevent hemorrhagic cystitis associated with specific chemotherapy agents.

Endocrine and Neuroendocrine Support

  • Octreotide Injection

Octreotide plays an important role in managing hormone-secreting tumors and neuroendocrine disorders.

Manufacturing Excellence

Taj Pharma operates under stringent quality standards and follows internationally recognized manufacturing practices. The company’s manufacturing facilities are designed to comply with global regulatory expectations, ensuring:

  • Consistent product quality
  • Batch-to-batch uniformity
  • Stringent quality control testing
  • Reliable supply chain management
  • Regulatory documentation support

The company emphasizes compliance with WHO-GMP standards and continuously invests in modern manufacturing technologies.

Global Partnership Opportunities

Taj Pharma actively collaborates with:

  • Pharmaceutical distributors
  • Government procurement agencies
  • Hospital supply organizations
  • Oncology treatment centers
  • International pharmaceutical companies

The company supports partners through:

  • Dossier and regulatory documentation
  • Product registration assistance
  • Competitive commercial terms
  • Long-term supply agreements
  • Private label and contract manufacturing opportunities

Future Outlook

The global oncology market continues to expand rapidly as cancer incidence rises and healthcare access improves across emerging economies. Taj Pharma remains committed to strengthening its oncology portfolio by introducing advanced therapies, expanding manufacturing capabilities, and supporting healthcare providers worldwide.

By combining quality manufacturing, regulatory expertise, and a comprehensive oncology product range, Taj Pharma is positioned as a reliable partner in the fight against cancer and in improving patient access to essential cancer medicines worldwide.

From chemotherapy agents and targeted therapies to hormonal treatments and supportive care products, Taj Pharma offers a comprehensive oncology portfolio designed to address the evolving needs of modern cancer treatment. Through innovation, quality assurance, and global partnerships, the company continues to contribute to better healthcare outcomes and expanded access to critical oncology medicines across international markets.

Taj Pharma Oncology Portfolio: Delivering High-Quality Cancer Medicines to Global Markets

Introduction

Cancer continues to be one of the world’s most significant healthcare challenges, affecting millions of patients annually. The growing demand for affordable, high-quality oncology medicines has created opportunities for pharmaceutical companies capable of delivering innovative and reliable treatment solutions. Taj Pharma stands at the forefront of this mission, offering a comprehensive oncology portfolio that supports healthcare providers, hospitals, government procurement agencies, and pharmaceutical distributors worldwide.

With a commitment to quality, regulatory compliance, and patient-centric healthcare, Taj Pharma manufactures a broad range of oncology and supportive care products designed to meet international standards while improving access to essential cancer therapies.

The Growing Need for Oncology Medicines

The global cancer burden continues to rise due to population growth, aging demographics, lifestyle factors, and improved diagnostic capabilities. As a result, healthcare systems are increasingly investing in advanced oncology treatments that provide better patient outcomes and enhanced quality of life.

Modern cancer treatment requires a combination of chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and supportive care medicines. Taj Pharma’s oncology portfolio addresses these requirements through a diverse range of products covering multiple therapeutic segments.

Comprehensive Oncology Product Portfolio

Hormonal Cancer Therapies

Hormonal therapies remain a cornerstone in the treatment of hormone-sensitive cancers such as breast and prostate cancer.

Taj Pharma’s hormonal therapy portfolio includes:

  • Anastrozole Tablets
  • Fulvestrant Injection
  • Enzalutamide Tablets

These products help inhibit hormonal pathways that contribute to tumor growth, offering effective treatment options for patients with hormone-dependent malignancies.

Targeted Cancer Therapies

Targeted therapies have transformed oncology by focusing on specific molecular pathways responsible for cancer progression.

Taj Pharma manufactures a growing range of targeted oncology medicines, including:

  • Imatinib Tablets and Capsules
  • Dasatinib Tablets
  • Cabozantinib Tablets
  • Sorafenib Tablets
  • Lapatinib Tablets
  • Everolimus Tablets
  • Bortezomib Injection

These advanced therapies are widely used in the treatment of chronic myeloid leukemia, renal cell carcinoma, hepatocellular carcinoma, breast cancer, gastrointestinal stromal tumors, and multiple myeloma.

Chemotherapy and Cytotoxic Agents

Conventional chemotherapy continues to play a critical role in comprehensive cancer treatment programs.

Taj Pharma’s chemotherapy portfolio includes:

  • Cyclophosphamide Tablets and Injection
  • Bendamustine Lyophilized Injection
  • Dacarbazine Injection
  • Vincristine Sulphate Injection
  • Etoposide Capsules and Injection
  • Fluorouracil Injection
  • Methotrexate Injection
  • Irinotecan Injection
  • Lomustine Capsules
  • Capecitabine Tablets

These medicines are utilized across various oncology protocols for the treatment of breast cancer, colorectal cancer, lymphoma, leukemia, lung cancer, and several other malignancies.

Specialized Hematology and Multiple Myeloma Treatments

The increasing prevalence of hematological cancers has highlighted the need for specialized therapies capable of improving patient outcomes.

Taj Pharma’s hematology portfolio includes:

  • Bortezomib Injection
  • Pomalidomide Capsules
  • Imatinib Tablets
  • Dasatinib Tablets

These therapies support the treatment of multiple myeloma, chronic myeloid leukemia, and other blood-related cancers, helping clinicians manage complex treatment regimens effectively.

Supportive Care Solutions for Oncology Patients

Successful cancer treatment extends beyond tumor management. Supportive care products play a vital role in reducing treatment-related complications and improving patient comfort.

Bone Metastasis Management

Patients with advanced cancers often experience bone-related complications requiring specialized therapies.

Available products include:

  • Denosumab Injection
  • Zoledronic Acid Injection

These medicines help reduce skeletal-related events and support long-term bone health in oncology patients.

Antiemetic Therapy

Chemotherapy-induced nausea and vomiting can significantly impact treatment adherence and quality of life.

Taj Pharma offers:

  • Ondansetron Injection

This widely used antiemetic helps improve patient comfort during chemotherapy treatment cycles.

Uroprotective Care

Certain chemotherapy agents require additional protection against bladder toxicity.

Products include:

  • Mesna Injection
  • Mesna Oral Capsules

Mesna is an essential supportive care medicine that helps prevent chemotherapy-induced urinary complications.

Endocrine and Neuroendocrine Tumor Management

Taj Pharma also manufactures:

  • Octreotide Injection

This product is commonly used in the management of neuroendocrine tumors and hormone-secreting conditions.

Commitment to Quality Manufacturing

Taj Pharma operates advanced pharmaceutical manufacturing facilities that comply with internationally recognized quality standards.

The company’s quality-focused approach includes:

  • WHO-GMP compliant manufacturing
  • PIC/S aligned quality systems
  • ISO 9001:2018 certification
  • Comprehensive quality control procedures
  • Strict regulatory compliance
  • Robust pharmacovigilance practices

Every product undergoes rigorous testing to ensure safety, efficacy, and consistency before reaching global healthcare markets.

Global Pharmaceutical Partnership Opportunities

Taj Pharma actively collaborates with:

  • Pharmaceutical distributors
  • Government healthcare agencies
  • Hospital procurement organizations
  • International pharmaceutical companies
  • Oncology treatment centers

The company provides extensive support through:

  • Regulatory dossiers and CTD documentation
  • Product registration assistance
  • Contract manufacturing services
  • Private label manufacturing
  • Long-term supply agreements
  • International market expansion support

Why Choose Taj Pharma for Oncology Products?

Key advantages include:

  • Extensive oncology product portfolio
  • WHO-GMP certified manufacturing facilities
  • Competitive global pricing
  • Reliable supply chain management
  • Regulatory expertise
  • Strong international market presence
  • Commitment to quality and patient safety

These strengths make Taj Pharma a trusted partner for organizations seeking dependable oncology medicine suppliers.

Future Growth in Oncology

The oncology sector continues to experience rapid growth driven by advancements in cancer research, precision medicine, and improved healthcare infrastructure. Taj Pharma remains committed to expanding its oncology portfolio while supporting global healthcare systems through innovative, accessible, and high-quality cancer treatments.

By investing in research, manufacturing excellence, and strategic partnerships, the company aims to strengthen its position as a leading supplier of oncology medicines worldwide.

Taj Pharma’s comprehensive oncology portfolio reflects its dedication to improving access to essential cancer therapies across global markets. From chemotherapy agents and targeted therapies to hormonal treatments and supportive care products, the company provides healthcare professionals with trusted pharmaceutical solutions designed to support better patient outcomes.

For pharmaceutical distributors, government procurement agencies, hospitals, and healthcare providers, Taj Pharma remains a reliable partner in the ongoing fight against cancer.